Eye imaging study for diabetic retinopathy
Part of Eyes & vision, Heart & circulation, Hormones & metabolism clinical trials.
This study uses a special eye imaging test called OCT angiography to look at tiny blood vessels in the back of the eye. It aims to understand changes caused by diabetic retinopathy, which could help improve how we monitor and treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with diabetic retinopathy (a diabetes complication affecting the eyes).
- You can have a complete eye exam, including OCT and OCT angiography.
- You have a recent HbA1c blood test result (shows average blood sugar levels).
- You have not had prior vitreoretinal surgery (surgery on the back of the eye).
- You have no other retinal diseases (like retinal vein occlusion) or conditions like glaucoma that could affect the results.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a detailed eye scan (optical coherence tomography angiography) to look at how blood vessels in the retina are affected. It may help researchers better understand retinal vascular diseases, though some people will be excluded for safety or image-quality reasons.
This study uses a special camera to take detailed pictures of the back of the eye. It is for people with certain retinal diseases and also for healthy volunteers to compare the images.
This study looks for specific eye findings (“biomarkers”) in people with type 2 diabetes using eye imaging. It may help researchers better understand diabetic retinopathy and how to detect it earlier or more accurately.
This study uses a special type of eye scan (OCTA) to look at blood vessels in the back of the eye. It's for people with various eye conditions, and aims to help doctors see and understand these diseases better.
This study tests whether advanced eye imaging can predict how diabetic eye disease (retinopathy) may worsen over time. If you have type 2 diabetes and early to moderate diabetic retinopathy without swelling in the central part of the retina, you may be able to join.
This study looks back at medical records of people with type 2 diabetes to understand how diabetic eye disease (retinopathy) progresses and when treatment is needed. It may help doctors better predict risks and guide future care.
Hear when a new Diabetic Retinopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.